Thomas P Soloway - Net Worth and Insider Trading
Thomas P Soloway Net Worth
The estimated net worth of Thomas P Soloway is at least $3,871 dollars as of 2024-05-27. Thomas P Soloway is the SVP, Operations and CFO of Paratek Pharmaceuticals Inc and owns about 1,736 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $3,871. Details can be seen in Thomas P Soloway's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas P Soloway has not made any transactions after 2011-12-01 and currently still holds the listed stock(s).
Transaction Summary of Thomas P Soloway
Thomas P Soloway Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas P Soloway owns 4 companies in total, including Satsuma Pharmaceuticals Inc (STSA) , Audentes Therapeutics Inc (BOLD) , and Paratek Pharmaceuticals Inc (PRTK) among others .
Click here to see the complete history of Thomas P Soloway’s form 4 insider trades.
Insider Ownership Summary of Thomas P Soloway
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STSA | Satsuma Pharmaceuticals Inc | 2023-06-08 | director |
| BOLD | Audentes Therapeutics Inc | 2020-01-15 | Executive Vice President & CFO |
| PRTK | Paratek Pharmaceuticals Inc | 2011-12-01 | SVP & Operations and CFO |
 | | 2022-09-14 | director |
Thomas P Soloway Latest Holdings Summary
Thomas P Soloway currently owns a total of 1 stock. Thomas P Soloway owns 1,736 shares of Paratek Pharmaceuticals Inc (PRTK) as of December 1, 2011, with a value of $3,871.
Latest Holdings of Thomas P Soloway
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2011-12-01 | 1,736 | 2.23 | 3,871 |
Holding Weightings of Thomas P Soloway
Thomas P Soloway Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas P Soloway has made a total of 0 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 5,222 shares on December 1, 2011, which brought Thomas P Soloway around $528,308.
Insider Trading History of Thomas P Soloway
- 1
Thomas P Soloway Trading Performance
Thomas P Soloway Ownership Network
Thomas P Soloway Owned Company Details
What does Satsuma Pharmaceuticals Inc do?
Who are the key executives at Satsuma Pharmaceuticals Inc?
Thomas P Soloway is the director of Satsuma Pharmaceuticals Inc. Other key executives at Satsuma Pharmaceuticals Inc include 10 percent owner Shin Nippon Biomedical Laboratories, Ltd. , director & 10 percent owner Ken Takanashi , and 10 percent owner Braden Michael Leonard .
Satsuma Pharmaceuticals Inc (STSA) Insider Trades Summary
Over the past 18 months, Thomas P Soloway made no insider transaction in Satsuma Pharmaceuticals Inc (STSA). Other recent insider transactions involving Satsuma Pharmaceuticals Inc (STSA) include a net purchase of 30,477,313 shares made by Shin Nippon Biomedical Laboratories, Ltd. , and a net purchase of 22,053,581 shares made by Ken Takanashi .
In summary, during the past 3 months, insiders sold 0 shares of Satsuma Pharmaceuticals Inc (STSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Satsuma Pharmaceuticals Inc (STSA) were sold and 52,530,894 shares were bought by its insiders, resulting in a net purchase of 52,530,894 shares.
Satsuma Pharmaceuticals Inc (STSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Satsuma Pharmaceuticals Inc Insider Transactions
Thomas P Soloway Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas P Soloway. You might contact Thomas P Soloway via mailing address: C/o Audentes Therapeutics, Inc., 600 California St., 17th Floor, San Francisco Ca 94108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
